Avelumab is a humanized anti-PD-L1 monoclonal antibody that binds to PD-L1 with high specificity (Kd = 0.1 nM) and exhibits potential antibody-dependent cell-mediated cytotoxicity (ADCC). Avelumab exerts a dual mechanism of action, combining direct antitumor activity with ADCC. Avelumab is used in research on cancers such as Merkel cell carcinoma.
Purity:
95.00%
CAS Number:
[1537032-82-8]
Target:
PD-1/PD-L1
T9903
T9903
* VAT and and shipping costs not included. Errors and price changes excepted
